RECRUITING

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Official Title

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Quick Facts

Study Start:2006-09
Study Completion:2040-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00616317

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Minute to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age or younger at the onset of disease
  2. * Presence of Vascular Thrombosis
  3. * UC Davis patient
  4. * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
  1. * Infants born to mothers with APS
  2. * Infants with congenital thrombophilia

Contacts and Locations

Study Contact

Lavjay Butani
CONTACT
(916) 734-8118

Principal Investigator

Lavjay Butani, M.D.
PRINCIPAL_INVESTIGATOR
University of California, Davis

Study Locations (Sites)

UC Davis Medical Center
Sacramento, California, 95817
United States

Collaborators and Investigators

Sponsor: University of California, Davis

  • Lavjay Butani, M.D., PRINCIPAL_INVESTIGATOR, University of California, Davis

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2006-09
Study Completion Date2040-01

Study Record Updates

Study Start Date2006-09
Study Completion Date2040-01

Terms related to this study

Keywords Provided by Researchers

  • Antiphospholipid Syndrome

Additional Relevant MeSH Terms

  • Antiphospholipid Syndrome